MARIA ESPINOZA to Humans
This is a "connection" page, showing publications MARIA ESPINOZA has written about Humans.
Connection Strength
0.011
-
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2023 02 01; 29(3):548-559.
Score: 0.006
-
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS Med. 2021 03; 18(3):e1003415.
Score: 0.005